Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Asset Writedowns and Impairment (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Asset Writedowns and Impairment for 10 consecutive years, with $27000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 102.05% to $27000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.2 million through Dec 2025, up 3.03% year-over-year, with the annual reading at -$1.2 million for FY2025, 3.03% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $27000.0 at Niagen Bioscience, up from -$12000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $400000.0 in Q2 2023, with the low at -$1.3 million in Q1 2025.
  • Average Asset Writedowns and Impairment over 5 years is -$119450.0, with a median of $13000.0 recorded in 2021.
  • The sharpest move saw Asset Writedowns and Impairment skyrocketed 8100.0% in 2023, then tumbled 3874.29% in 2025.
  • Over 5 years, Asset Writedowns and Impairment stood at $198000.0 in 2021, then crashed by 82.32% to $35000.0 in 2022, then crashed by 2791.43% to -$942000.0 in 2023, then tumbled by 39.49% to -$1.3 million in 2024, then surged by 102.05% to $27000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $27000.0, -$12000.0, and $89000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.